$FATE
FATE THERAPEUTICS INC

2018 Q1 Form 10-K Financial Statement

#000156459018004394 Filed on March 05, 2018

View on sec.gov

Income Statement

Concept 2018 Q1 2017 Q4 2017 Q3
Revenue $1.026M $1.027M $1.026M
YoY Change -0.1% 0.0% 0.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.600M $3.380M $2.790M
YoY Change 18.81% 37.96% 6.9%
% of Gross Profit
Research & Development $11.48M $9.890M $8.578M
YoY Change 43.99% 58.75% 26.07%
% of Gross Profit
Depreciation & Amortization $286.0K $290.0K $240.0K
YoY Change 38.83% 45.0% 9.09%
% of Gross Profit
Operating Expenses $15.08M $13.27M $11.37M
YoY Change 37.12% 52.87% 20.72%
Operating Profit -$10.34M
YoY Change 23.26%
Interest Expense -$80.00K -$250.0K $378.0K
YoY Change -50.0% -13.79% -1.82%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$14.14M -$12.50M -$10.68M
YoY Change 39.59% 57.43% 22.2%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$14.14M -$12.50M -$10.68M
YoY Change 39.59% 57.39% 22.28%
Net Earnings / Revenue -1377.68% -1216.85% -1041.33%
Basic Earnings Per Share
Diluted Earnings Per Share -$268.0K -$286.0K -$257.8K
COMMON SHARES
Basic Shares Outstanding 52.77M
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q1 2017 Q4 2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $88.60M $100.9M $69.20M
YoY Change 7.65% 9.55% 48.5%
Cash & Equivalents $33.03M $88.95M $43.35M
Short-Term Investments $55.70M $12.00M $26.00M
Other Short-Term Assets $1.500M $1.600M $800.0K
YoY Change 36.36% 33.33% 0.0%
Inventory
Prepaid Expenses
Receivables $500.0K
Other Receivables $0.00
Total Short-Term Assets $90.60M $102.6M $70.00M
YoY Change 8.63% 9.94% 47.68%
LONG-TERM ASSETS
Property, Plant & Equipment $2.600M $2.550M $2.500M
YoY Change 52.94% 61.49% 38.89%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $100.0K $24.00K $100.0K
YoY Change 0.0% 0.0% 0.0%
Total Long-Term Assets $2.800M $2.696M $2.700M
YoY Change 47.37% 56.29% 42.11%
TOTAL ASSETS
Total Short-Term Assets $90.60M $102.6M $70.00M
Total Long-Term Assets $2.800M $2.696M $2.700M
Total Assets $93.40M $105.3M $72.70M
YoY Change 9.5% 10.78% 47.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.200M $1.678M $2.200M
YoY Change -12.0% 79.66% 83.33%
Accrued Expenses $7.400M $7.254M $5.400M
YoY Change 57.45% 83.32% 63.64%
Deferred Revenue $2.105M
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $800.0K $0.00 $0.00
YoY Change -89.5% -100.0% -100.0%
Total Short-Term Liabilities $12.60M $11.05M $9.700M
YoY Change -25.43% -27.25% -33.91%
LONG-TERM LIABILITIES
Long-Term Debt $14.10M $14.81M $14.80M
YoY Change 1181.82% 492.08% 221.04%
Other Long-Term Liabilities $1.800M $2.200M $2.400M
YoY Change -48.57% -47.62% -47.83%
Total Long-Term Liabilities $15.90M $14.81M $17.20M
YoY Change 245.65% 492.08% 273.1%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.60M $11.05M $9.700M
Total Long-Term Liabilities $15.90M $14.81M $17.20M
Total Liabilities $28.40M $25.86M $26.90M
YoY Change 32.09% 46.18% 39.46%
SHAREHOLDERS EQUITY
Retained Earnings -$218.8M
YoY Change 24.43%
Common Stock $53.00K
YoY Change -99.98%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $65.00M $77.19M $45.75M
YoY Change
Total Liabilities & Shareholders Equity $93.40M $105.3M $72.70M
YoY Change 9.5% 10.78% 47.48%

Cashflow Statement

Concept 2018 Q1 2017 Q4 2017 Q3
OPERATING ACTIVITIES
Net Income -$14.14M -$12.50M -$10.68M
YoY Change 39.59% 57.39% 22.28%
Depreciation, Depletion And Amortization $286.0K $290.0K $240.0K
YoY Change 38.83% 45.0% 9.09%
Cash From Operating Activities -$12.55M -$10.81M -$9.770M
YoY Change 68.24% 43.18% 30.09%
INVESTING ACTIVITIES
Capital Expenditures $184.0K -$800.0K -$360.0K
YoY Change 18.71% 1900.0% 800.0%
Acquisitions
YoY Change
Other Investing Activities -$43.66M $14.00M $14.00M
YoY Change 14.23% 132.56% 2757.14%
Cash From Investing Activities -$43.84M $13.20M $13.64M
YoY Change 14.24% 120.74% 2865.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 355.0K 43.32M 8.300M
YoY Change -116.36% -18.4% 0.24%
NET CHANGE
Cash From Operating Activities -12.55M -10.81M -9.770M
Cash From Investing Activities -43.84M 13.20M 13.64M
Cash From Financing Activities 355.0K 43.32M 8.300M
Net Change In Cash -56.04M 45.71M 12.17M
YoY Change 16.73% -11.28% 889.43%
FREE CASH FLOW
Cash From Operating Activities -$12.55M -$10.81M -$9.770M
Capital Expenditures $184.0K -$800.0K -$360.0K
Free Cash Flow -$12.74M -$10.01M -$9.410M
YoY Change 67.24% 33.29% 25.97%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1678000
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7254000
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
24000
CY2017Q4 us-gaap Assets
Assets
105292000
CY2016Q4 us-gaap Assets
Assets
95048000
CY2016Q4 us-gaap Assets Current
AssetsCurrent
93323000
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3957000
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2550000
CY2016Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
4000
CY2016Q4 fate Short Term Investments And Related Maturity Receivables
ShortTermInvestmentsAndRelatedMaturityReceivables
3503000
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
934000
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1579000
CY2017Q4 fate Short Term Investments And Related Maturity Receivables
ShortTermInvestmentsAndRelatedMaturityReceivables
11997000
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1211000
CY2017Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
1347000
CY2016Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
101000
CY2017Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
724000
CY2016Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
2829000
CY2017Q4 us-gaap Accounts Payable And Accrued Liabilities Noncurrent
AccountsPayableAndAccruedLiabilitiesNoncurrent
175000
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
295934000
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3000
CY2016Q4 us-gaap Accounts Payable And Accrued Liabilities Noncurrent
AccountsPayableAndAccruedLiabilitiesNoncurrent
1276000
CY2017Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
14808000
CY2017 dei Trading Symbol
TradingSymbol
FATE
CY2017Q2 dei Entity Public Float
EntityPublicFloat
122330000
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
3000
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
53000
CY2018Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
52769156
CY2017 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2017 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2015 us-gaap Contracts Revenue
ContractsRevenue
2431000
CY2017 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-118000
CY2015 us-gaap Interest Expense
InterestExpense
2220000
CY2016 us-gaap Interest Expense
InterestExpense
1637000
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-42125000
CY2017 us-gaap Investment Income Interest
InvestmentIncomeInterest
559000
CY2016 us-gaap Investment Income Interest
InvestmentIncomeInterest
138000
CY2016Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2501000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
95048000
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
41386506
CY2016Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
8187000
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11049000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
15187000
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
3000
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
41000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
248957000
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
41386506
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
73154000
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-218798000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
88609000
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1647000
CY2017Q4 us-gaap Assets Current
AssetsCurrent
102596000
CY2017Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
122000
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
122000
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
24000
CY2017Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
12000
CY2017Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2105000
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2105000
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-175846000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
77189000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
105292000
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
52648601
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
52648601
CY2016 us-gaap Contracts Revenue
ContractsRevenue
4402000
CY2015 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2210000
CY2017 us-gaap Interest Expense
InterestExpense
1268000
CY2016 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3184000
CY2015 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2400000
CY2017 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
81000
CY2016 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
139000
CY2015 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
176000
CY2016 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1000
CY2017 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
226000
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3606000
CY2017 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
217000
CY2017 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
42979000
CY2017 fate Common Stock Issued During Period Value Private Placement
CommonStockIssuedDuringPeriodValuePrivatePlacement
-13000
CY2017 fate Convertible Preferred Stock Issued During Period Value New Issues
ConvertiblePreferredStockIssuedDuringPeriodValueNewIssues
-26000
CY2017 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-2000
CY2017 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
971000
CY2016 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
881000
CY2015 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
687000
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3606000
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-29992000
CY2017 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-2000
CY2016 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-1000
CY2017 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-42954000
CY2016 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-33463000
CY2015 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-29992000
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.02
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.05
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.18
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
41982167
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
31754140
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
25484262
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
28340000
CY2015 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
420000
CY2015 fate Adjustments To Additional Paid In Capital Repurchase Liability For Unvested Equity Awards
AdjustmentsToAdditionalPaidInCapitalRepurchaseLiabilityForUnvestedEquityAwards
44000
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2400000
CY2015 fate Incentive Bonuses Paid In Value
IncentiveBonusesPaidInValue
97000
CY2015 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
32149000
CY2015 fate Common Stock Issued Value To Collaborative Partner
CommonStockIssuedValueToCollaborativePartner
4580000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
38038000
CY2016 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
187000
CY2016 fate Adjustments To Additional Paid In Capital Repurchase Liability For Unvested Equity Awards
AdjustmentsToAdditionalPaidInCapitalRepurchaseLiabilityForUnvestedEquityAwards
1000
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3184000
CY2016 fate Common Stock Issued During Period Value Private Placement
CommonStockIssuedDuringPeriodValuePrivatePlacement
28797000
CY2016 fate Convertible Preferred Stock Issued During Period Value New Issues
ConvertiblePreferredStockIssuedDuringPeriodValueNewIssues
36289000
CY2016 fate Incentive Bonuses Paid In Value
IncentiveBonusesPaidInValue
121000
CY2017 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
25000
CY2016 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-171000
CY2017 us-gaap Paid In Kind Interest
PaidInKindInterest
321000
CY2016 us-gaap Paid In Kind Interest
PaidInKindInterest
492000
CY2015 us-gaap Paid In Kind Interest
PaidInKindInterest
651000
CY2017 us-gaap Straight Line Rent
StraightLineRent
-1085000
CY2016 us-gaap Straight Line Rent
StraightLineRent
7000
CY2015 us-gaap Straight Line Rent
StraightLineRent
24000
CY2017 fate Deferred Revenue Expense
DeferredRevenueExpense
2105000
CY2016 fate Deferred Revenue Expense
DeferredRevenueExpense
2401000
CY2015 fate Deferred Revenue Expense
DeferredRevenueExpense
-7335000
CY2017 us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
30000
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
428000
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
381000
CY2015 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
107000
CY2017 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2511000
CY2016 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
7689000
CY2015 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1546000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
88731000
CY2015Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
64931000
CY2014Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
49223000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
89074000
CY2017 us-gaap Interest Paid
InterestPaid
2314000
CY2017 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
10000
CY2017 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
47444000
CY2016 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
57737000
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
35603000
CY2017 fate Cash Cash Equivalents And Restricted Cash Period Increase Decrease
CashCashEquivalentsAndRestrictedCashPeriodIncreaseDecrease
343000
CY2016 fate Cash Cash Equivalents And Restricted Cash Period Increase Decrease
CashCashEquivalentsAndRestrictedCashPeriodIncreaseDecrease
23800000
CY2015 fate Cash Cash Equivalents And Restricted Cash Period Increase Decrease
CashCashEquivalentsAndRestrictedCashPeriodIncreaseDecrease
15708000
CY2016 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1561000
CY2015 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
477000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-36905000
CY2016 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-29823000
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-18397000
CY2016 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
18000
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1725000
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
457000
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1498000
CY2017 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
39971000
CY2016 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
19675000
CY2017 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
31500000
CY2016 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
16000000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-10196000
CY2016 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-4114000
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1498000
CY2017 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
205000
CY2016 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
186000
CY2015 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
420000
CY2017 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
43206000
CY2015 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
32149000
CY2015 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4580000
CY2017 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
15000000
CY2017 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
10764000
CY2016 us-gaap Interest Paid
InterestPaid
1067000
CY2015 us-gaap Interest Paid
InterestPaid
1353000
CY2017 fate Issuance Of Warrants In Connection With Long Term Debt
IssuanceOfWarrantsInConnectionWithLongTermDebt
217000
CY2017 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk</p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">Financial instruments, which potentially subject the Company to a significant concentration of credit risk, consist primarily of cash and cash equivalents, and short-term investments. The Company maintains deposits in federally insured financial institutions in excess of federally insured limits. The Company has not experienced any losses in such accounts and management believes that the Company is not exposed to significant credit risk due to the financial position of the depository institutions in which those deposits and investments are held. </p></div>
CY2017 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">The Company&#8217;s consolidated financial statements are prepared in accordance with United States generally accepted accounting principles (GAAP). The preparation of the Company&#8217;s consolidated financial statements requires it to make estimates and assumptions that impact the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingent assets and liabilities in the Company&#8217;s consolidated financial statements and accompanying notes. The most significant estimates in the Company&#8217;s consolidated financial statements relate to accrued expenses. Although these estimates are based on the Company&#8217;s knowledge of current events and actions it may undertake in the future, actual results may ultimately materially differ from these estimates and assumptions.</p></div>
CY2017Q4 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
64809000
CY2015Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
122000
CY2017 us-gaap Revenue Recognition Milestone Method Factors
RevenueRecognitionMilestoneMethodFactors
(i) persuasive evidence that an agreement exists; (ii) delivery of the products and/or services has occurred; (iii) the selling price is fixed or determinable; and (iv) collectability is reasonably assured.
CY2017 us-gaap Income Tax Examination Likelihood Of Unfavorable Settlement
IncomeTaxExaminationLikelihoodOfUnfavorableSettlement
more than 50 percent
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
19994169
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
18667458
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7689000
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5783000
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5139000
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4204000
CY2017Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
1761000
CY2016Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
1505000
CY2017Q4 fate Accrued Clinical Trial Related Costs Current
AccruedClinicalTrialRelatedCostsCurrent
3323000
CY2015 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3246837
CY2017Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
12000000
CY2016Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
3504000
CY2017Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
3000
CY2016Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1000
CY2017Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
11997000
CY2016Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
3503000
CY2017 us-gaap Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
0
CY2017 us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
0
CY2016 us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
0
CY2017 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2017Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2017Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2017Q4 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2016Q4 fate Accrued Clinical Trial Related Costs Current
AccruedClinicalTrialRelatedCostsCurrent
1043000
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2170000
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1409000
CY2017Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
15000000
CY2016Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
10765000
CY2017Q4 fate Debt Instrument Discount Non Current
DebtInstrumentDiscountNonCurrent
192000
CY2016Q4 fate Debt Instrument Discount Non Current
DebtInstrumentDiscountNonCurrent
7000
CY2017Q4 fate Long Term Debt Net Of Long Term Portion Of Debt Issuance Costs And Discounts
LongTermDebtNetOfLongTermPortionOfDebtIssuanceCostsAndDiscounts
14808000
CY2016Q4 fate Long Term Debt Net Of Long Term Portion Of Debt Issuance Costs And Discounts
LongTermDebtNetOfLongTermPortionOfDebtIssuanceCostsAndDiscounts
10758000
CY2016Q4 fate Long Term Debt Gross Current
LongTermDebtGrossCurrent
8257000
CY2016Q4 fate Debt Instrument Discount Current
DebtInstrumentDiscountCurrent
70000
CY2017Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
100000
CY2017 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
2300000
CY2016 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1300000
CY2015 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1200000
CY2017 fate Minimum Annual Payments To Maintain Licenses
MinimumAnnualPaymentsToMaintainLicenses
200000
CY2017 fate Income Tax Reconciliation Permanent Tax Differences
IncomeTaxReconciliationPermanentTaxDifferences
795000
CY2016 fate Income Tax Reconciliation Permanent Tax Differences
IncomeTaxReconciliationPermanentTaxDifferences
292000
CY2015 fate Income Tax Reconciliation Permanent Tax Differences
IncomeTaxReconciliationPermanentTaxDifferences
43000
CY2017 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
539000
CY2016 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
968000
CY2015 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
213000
CY2017 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
2934000
CY2016 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
971000
CY2015 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
594000
CY2017Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
1215000
CY2017Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
5645000
CY2017Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
5661000
CY2017Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
5253000
CY2017Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
1545000
CY2017Q4 us-gaap Long Term Debt
LongTermDebt
19319000
CY2017Q4 fate Long Term Debt Maturities Repayments Interest Included In Payments
LongTermDebtMaturitiesRepaymentsInterestIncludedInPayments
3194000
CY2017Q4 fate Long Term Debt Maturities Additional Payments Due On Maturity
LongTermDebtMaturitiesAdditionalPaymentsDueOnMaturity
1125000
CY2017Q4 fate Unamortized Debt Discounts And Debt Issuance Cost
UnamortizedDebtDiscountsAndDebtIssuanceCost
192000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
2116000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
2278000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
2346000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
2417000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
2489000
CY2017Q4 fate Operating Leases Future Minimum Payments Due In Six Years
OperatingLeasesFutureMinimumPaymentsDueInSixYears
1282000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
12928000
CY2017Q4 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
3331000
CY2017Q4 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
7923000
CY2017Q4 us-gaap Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
8007000
CY2017Q4 us-gaap Contractual Obligation Due In Fourth Year
ContractualObligationDueInFourthYear
7670000
CY2017Q4 us-gaap Contractual Obligation Due In Fifth Year
ContractualObligationDueInFifthYear
4034000
CY2017Q4 fate Contractual Obligation Due In Sixth Year
ContractualObligationDueInSixthYear
1282000
CY2017Q4 us-gaap Contractual Obligation
ContractualObligation
32247000
CY2017 us-gaap Dividends
Dividends
0
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
0
CY2017Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
24395281
CY2016Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
20456523
CY2017 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-14603000
CY2016 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-11377000
CY2015 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-10198000
CY2017 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-1315000
CY2016 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-2089000
CY2015 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
2226000
CY2017 fate Income Tax Reconciliation Reserve For Uncertain Tax Positions
IncomeTaxReconciliationReserveForUncertainTaxPositions
1326000
CY2016 fate Income Tax Reconciliation Reserve For Uncertain Tax Positions
IncomeTaxReconciliationReserveForUncertainTaxPositions
2076000
CY2015 fate Income Tax Reconciliation Reserve For Uncertain Tax Positions
IncomeTaxReconciliationReserveForUncertainTaxPositions
1733000
CY2016 fate Income Tax Reconciliation Tax Attribute Limitation
IncomeTaxReconciliationTaxAttributeLimitation
54000
CY2015 fate Income Tax Reconciliation Tax Attribute Limitation
IncomeTaxReconciliationTaxAttributeLimitation
2727000
CY2017 fate Tax Cuts And Jobs Act Of2017 Change In Tax Rate Income Tax Expense Benefit
TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit
25280000
CY2017 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
46000
CY2016 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-74000
CY2015 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-37000
CY2017 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-9134000
CY2016 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
11121000
CY2015 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
3887000
CY2017Q4 fate Deferred Tax Assets Section59e Amortization
DeferredTaxAssetsSection59eAmortization
14365000
CY2016Q4 fate Deferred Tax Assets Section59e Amortization
DeferredTaxAssetsSection59eAmortization
17699000
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
27699000
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
35049000
CY2017Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
5421000
CY2016Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
2175000
CY2017Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
581000
CY2016Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
1020000
CY2017Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
594000
CY2016Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
1677000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
876000
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1222000
CY2017Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
-96000
CY2016Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
76000
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
49632000
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
58766000
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
49632000
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
58766000
CY2017 fate Cumulative Change In Ownership Percentage
CumulativeChangeInOwnershipPercentage
0.50
CY2017 fate Period For Cumulative Change In Ownership
PeriodForCumulativeChangeInOwnership
P3Y
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1820000
CY2015 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
374000
CY2015 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
2624000
CY2015 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
949000
CY2015Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
3869000
CY2016 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
2268000
CY2016 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
1625000
CY2016 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
32000
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
7730000
CY2017 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
4077000
CY2017 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
6000
CY2017 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
13000
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
11800000
CY2017Q4 fate Unrecognized Tax Benefits Resulting In Net Operating Loss And Tax Credit Carryforward
UnrecognizedTaxBenefitsResultingInNetOperatingLossAndTaxCreditCarryforward
0
CY2017Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
0
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2017 fate Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Deferred Tax Liability Provisional Income Tax Benefit
TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxBenefit
25300000
CY2017 fate Tax Cuts And Jobs Act Of2017 Change In Tax Rate Deferred Tax Assets And Liabilities Income Tax Expense Benefit
TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetsAndLiabilitiesIncomeTaxExpenseBenefit
25300000
CY2009Q1 fate Defined Contribution Plan Minimum Age Of Employee
DefinedContributionPlanMinimumAgeOfEmployee
P21Y
CY2017 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
0
CY2017Q1 us-gaap Sales Revenue Net
SalesRevenueNet
1027000
CY2017Q2 us-gaap Sales Revenue Net
SalesRevenueNet
1026000
CY2017Q3 us-gaap Sales Revenue Net
SalesRevenueNet
1026000
CY2017Q4 us-gaap Sales Revenue Net
SalesRevenueNet
1027000
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
10998000
CY2017Q2 us-gaap Operating Expenses
OperatingExpenses
10596000
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
11366000
CY2017Q4 us-gaap Operating Expenses
OperatingExpenses
13271000
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-10126000
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-9645000
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-10684000
CY2017Q4 us-gaap Net Income Loss
NetIncomeLoss
-12497000
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.24
CY2017Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.23
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.26
CY2017Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.29
CY2016Q1 us-gaap Sales Revenue Net
SalesRevenueNet
1322000
CY2016Q2 us-gaap Sales Revenue Net
SalesRevenueNet
1027000
CY2016Q3 us-gaap Sales Revenue Net
SalesRevenueNet
1026000
CY2016Q4 us-gaap Sales Revenue Net
SalesRevenueNet
1027000
CY2016Q1 us-gaap Operating Expenses
OperatingExpenses
9238000
CY2016Q2 us-gaap Operating Expenses
OperatingExpenses
9031000
CY2016Q3 us-gaap Operating Expenses
OperatingExpenses
9415000
CY2016Q4 us-gaap Operating Expenses
OperatingExpenses
8681000
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-8377000
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-8408000
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-8737000
CY2016Q4 us-gaap Net Income Loss
NetIncomeLoss
-7940000
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.29
CY2016Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.29
CY2016Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.27
CY2016Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.21

Files In Submission

Name View Source Status
0001564590-18-004394-index-headers.html Edgar Link pending
0001564590-18-004394-index.html Edgar Link pending
0001564590-18-004394.txt Edgar Link pending
0001564590-18-004394-xbrl.zip Edgar Link pending
fate-10k_20171231.htm Edgar Link pending
fate-20171231.xml Edgar Link completed
fate-20171231.xsd Edgar Link pending
fate-20171231_cal.xml Edgar Link unprocessable
fate-20171231_def.xml Edgar Link unprocessable
fate-20171231_lab.xml Edgar Link unprocessable
fate-20171231_pre.xml Edgar Link unprocessable
fate-ex1032_90.htm Edgar Link pending
fate-ex105_89.htm Edgar Link pending
fate-ex108_147.htm Edgar Link pending
fate-ex231_6.htm Edgar Link pending
fate-ex311_8.htm Edgar Link pending
fate-ex321_9.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g2018030521411469735210.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending